Allergan pursuit of longer-acting toxin not a risk for Revance, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Seattle Genetics risk/reward favorable ahead of ASH, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Drug stocks are "no longer" reliable safety nets for investors: Cramer
Jim Cramer issues a warning to investors about the pharmaceutical sector, which includes high-profile stocks like Allergan and Gilead......»»
Higher rates: Sign of economic strength or a risk? Try both
This week's dizzying sell-offs in the financial markets have been a rude reminder that the U.S. economy is no longer relying on ultra-low interest rates to fuel growth......»»
Higher rates both a sign of US economic might and risk to it
This week's dizzying sell-offs in the financial markets have been a rude reminder that the U.S. economy is no longer relying on ultra-low interest rates to fuel growth. .....»»
Higher rates both a sign of US economic might and risk to it
This week's dizzying sell-offs in the financial markets have been a rude reminder that the U.S. economy is no longer relying on ultra-low interest rates to fuel growth. .....»»
"We Have Really Lost Our Way" - Trader Laments Market"s Risk Ignorance
"BTFD", "Goldilocks", "Climbing a wall of worry", "Powell Put", "Trump Put", "It's different this time." The excuses to buy stocks - no matter what headline tape bomb explodes - grow longer and more desperate as asset-gatherers and commission-.....»»
Revance selloff on Allergan data a buying opportunity, says Mizuho
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Red Hat remains well positioned over medium to longer-term, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
JMP: Changing Competitive Landscape Makes Revance Less Appealing
Revance Therapeutics Inc (NASDAQ: RVNC), a biotech company developing a botulinum toxin product, could face a competitive backlash, according to JMP Securities. Latest Ratings for RVNC Dat.....»»
Revance downgraded to Market Perform after Allergan data at JMP Securities
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alnylam data publication points to positive Onpattro risk profile, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Revance shares defended at Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pivotal: Snap No Longer A Sell, But Stock Could Still Fall
Shares of social media company Snap Inc (NYSE: SNAP) briefly fell below $9 per share Wednesday and are now trading at a more balanced risk-reward profile for the longer-term, according to Pivotal Research Group. Lates.....»»
Cowen downgrades Westlake Chemical to Market Perform on heightened margin risk
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Tesla CEO Musk drops pursuit of $72 billion take-private deal
Tesla Inc CEO Elon Musk said late on Friday he would no longer pursue a $72 billion deal to take his U.S. electric car maker private, abandoning an idea that had stunned investors and drawn regulatory scrutiny......»»
L Brands downside risk may persist, says Cowen
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
J. Jill downgraded as earnings at risk from changes to product and marketing
J. Jill Inc. was downgraded to market perform from outperform at Cowen & Co. with analysts seeing a risk to earnings from the changes to product, mark.....»»
P&G Raises Prices to Improve Margins
Strategy is fraught with risk as products may no longer command premium pricesRelated Stocks: PG,.....»»
People who sleep for longer than 8 hours could have a greater risk of dying early — but that doesn"t mean you should never sleep in
Nelli Syrotynska / Shutterstock A new study has shown too much sl.....»»
Qualcomm"s Risk-Reward Is Too Favorable to Ignore, Cowen Says In Upgrade
With QUALCOMM, Inc. Latest Ratings for.....»»